GILEAD SCIENCES, INC. — Director's Dealing 2018

Feb 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-02-01

Reporting Person: MILLIGAN JOHN F (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Non-qualified Stock Option (Right to Buy)	$83.49	A	295660	Acquired	2028-02-01	Common Stock (295660)	Direct

Footnotes

F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.